Skip to main content
. Author manuscript; available in PMC: 2015 May 22.
Published in final edited form as: Expert Rev Mol Diagn. 2009 Apr;9(3):243–257. doi: 10.1586/erm.09.10

Table 3.

Potentially useful methylation biomarkers for prognosis of prostate cancer

Methods Marker/Markers Prognosis Specimen References
QMSP PTGS2 X Primary tissue (53)
MSP GSTP1/APC
GSTP1/PTGS2
GSTP1/APC/PTGS2		 X Primary tissue (63)
MSP CD44/ PTGS2 X Primary tissue (48)
QMSP APC X Primary tissue (31)
Methylation
Microarray
and QMSP		 GPR7, ABHD9 and
Chr3-EST		 X Primary tissue (102)
MethyLight PTGS2, RAR-beta,
and EDNRB		 X Primary tissue (103)
MSP TMS1 X Primary tissue (41)
QMSP APC and cyclin D2 X Primary tissue (45)
MSP DRM, HPP1,
RUNX3		 X Primary tissue (104)
REQPCR GTSP1 X serum (105)
MSP LAMA3 X Primary tissue (62)
MSP Cyclin D2 X Primary tissue (44)
MSP RASSF1A X Primary tissue (65)